Decision Looms on Facility Licence Application

Australian Radiation Protection and Nuclear Safety Act 1998

Australian Radiation Protection and Nuclear Safety Regulations 2018

As required by the Australian Radiation Protection and Nuclear Safety Regulations 2018 (the Regulations), the CEO of ARPANSA gives notice she intends to make a decision under section 32 of the Australian Radiation Protection and Nuclear Safety Act 1998 (the Act) regarding the following application for a facility licence:

Application No. A01098 by the Australian Nuclear Science and Technology Organisation (ANSTO) to prepare a site for a nuclear installation, specifically a facility to manufacture nuclear medicines for the treatment of Australians, to be known as the 'ANSTO Nuclear Medicine Manufacturing Facility' (NMMF), at the Lucas Heights Science and Technology Centre in Lucas Heights, New South Wales 2234.

The NMMF is intended to replace the existing ANSTO facility currently used to produce nuclear medicines.

An overview of this licence application is now available for public comment through our Consultation Hub. Submissions close at 11:59pm on 28 May 2025.

A community information session will be held online on Wednesday, 30 April, from 6.30pm.

/Public Release. This material from the originating organization/author(s) might be of the point-in-time nature, and edited for clarity, style and length. Mirage.News does not take institutional positions or sides, and all views, positions, and conclusions expressed herein are solely those of the author(s).View in full here.